Skip to main content
. 2005 Jun 29;45(7):1160–1164. doi: 10.1111/j.1537-2995.2005.00179.x

Table 2.

Characteristics of the simulated IVIG

Source plasma Number of trials Purity (%) Monomer plus dimer (%) ACA (%) PKA (IU/mL) TnBP (µg/mL) Triton X‐100 (µg/mL) Yield (g/L) Titer recovery (%)
Normal 4 98.9 ± 0.3 100 25 ± 10 <9.3 NT* NT 3.8 ± 0.5 NA
Hepatitis B hyperimmune 4 99.0 ± 0.2 100 23 ± 11 <9.3 <2 <5 4.0 ± 0.3 48.5 ± 8.0
*

NT = not tested.

NA = not applicable.